{"id":203717,"name":"MYRIAD GENETICS, INC.","slug":"myriad-genetics-inc","state":"DC","country":"United States of America","description":"Molecular diagnostic company.","totalSpending":590000,"filings":21,"yearlySpending":[{"year":2019,"income":20000},{"year":2020,"income":120000},{"year":2021,"income":120000},{"year":2022,"income":120000},{"year":2023,"income":120000},{"year":2024,"income":90000}],"issues":[{"code":"MED","display":"Medical/Disease Research/Clinical Labs"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"BUD","display":"Budget/Appropriations"},{"code":"HCR","display":"Health Issues"},{"code":"VET","display":"Veterans"}],"firms":["BLUEBIRD STRATEGIES"],"lobbyists":["JOHN BRENNAN"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Issues related to regulation of pharmcogenomic tests. FY20 HHS Appropriations bill regarding CMS coverage policies for mental health genetic tests.","Issues related to regulation of pharmcogenomic tests. FY20 HHS Appropriations bill regarding CMS coverage policies for mental health genetic tests.","Issues related to regulation of pharmcogenomic tests. FY20 HHS Appropriations bill regarding CMS coverage policies for mental health genetic tests.","Medicare coverage policies for mental health genetic tests.","Draft legislation to regulate clinical labs under CLIA and FDA."]}